Lindsay A. Rosenwald MD - 25 Jun 2026 Form 4 Insider Report for Journey Medical Corp (DERM)

Reporting relationship: Director
Issuer ticker: DERM
Reported as of: 25 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 26 Jun 2026, 16:14:27 UTC
Prior SEC filing: 20 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Ramsey Alloush, attorney-in-fact

Key filing fact

Lindsay A. Rosenwald MD filed Form 4 for Journey Medical Corp (DERM) on 26 Jun 2026.

Key facts

This page summarizes Lindsay A. Rosenwald MD's Form 4 filing for Journey Medical Corp (DERM).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Jun 2026, 16:14.

Change

Previous filing in this sequence was filed on 20 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000941841 Primary reporting owner

ROSENWALD LINDSAY A MD

Relationship: Director
Address: C/O JOURNEY MEDICAL CORPORATION, 9237 E VIA DE VENTURA BLVD., SUITE 105, SCOTTSDALE
Signature: /s/ Ramsey Alloush, attorney-in-fact
Signature date: 26 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DERM transaction

Common Stock, $0.0001 par value

Award

Transaction value
Shares: +10,000
Change %: +4.7%
Price: $0.000000^*
Shares after: 221,146
Date: 25 Jun 2026
Ownership: Direct
Footnotes: F1, F2

DERM holding

Common Stock, $0.0001 par value

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 176,470
Date: 25 Jun 2026
Ownership: See Footnote
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On June 25, 2026, the reporting person was granted 10,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 10,000 shares on June 25, 2027.

Footnote F2

Includes restricted stock units, which vest over various time periods.

Footnote F3

The shares are held by a limited liability company over which the reporting person, as managing member, is deemed to have voting and investment power.